Enoxaparinsodiumisawidelyusedanticoagulantdrugthathascontributedsignificantlytothetreatmentandpreventionofthromboticdisorders.EnoxaparinsodiumAPI(ActivePharmaceuticalIngredient)playsacriticalroleinthe
HeparinsodiumAPI(activepharmaceuticalingredient)isatypeofanticoagulantmedicationusedtopreventandtreatbloodclotsinthebody.ThemechanismofactionofheparinsodiumAPIisbasedonitsinteractionswithspecificclott
Lowmolecularweightheparinsodiumisananticoagulantmedicationthatiscommonlyusedtopreventandtreatbloodclots.Itisasyntheticformofheparinthathasalowermolecularweightthanstandardheparin.Thisallowsformorepred
EnoxaparinsodiumAPIisananticoagulantmedicationusedtopreventandtreatbloodclots.Itisalow-molecular-weightheparin(LMWH)madebydepolymerizingstandardheparin,whichisderivedfromtheintestinalmucosaofpigsorcow